01
Name what's in the bottle
Genus, species, strain ID — on every label. No proprietary blends, no "probiotic complex."
"Name every strain
Disclose every dose
Cite every claim"
— THE PRINCIPLE METABOLICA WAS BUILT ON · HOWARD FIELDS, PRESIDENT & CEO
Metabolica Health is a Montréal-based bioscience company. We develop evidence-based formulations built around the gut–brain–metabolism connection — using named, clinically studied strains and ingredients at the doses used in published research.
Because your body works as one system, we formulate to support the systems that help it respond, recover, and adapt. Our work is backed by peer-reviewed publications, patents, and collaborations with leading academic institutions.
People deserve to know what they are taking, why they are taking it, and the science behind it.
01
Genus, species, strain ID — on every label. No proprietary blends, no "probiotic complex."
02
Not the marketing dose. The amount used in the published research.
03
Every health statement traces back to a named strain or mechanism, tagged on the page and linked to the source.
Advisory board public, first study published, three consumer formulations defined.
AM/PM ritual for stress resilience and restorative sleep.
Targeted support for calm focus when stress rises.
Daily formulation to support a healthy metabolism and digestive comfort, alongside a balanced diet and active lifestyle.
ACREOS™ is the next-generation platform — a research program built around a naturally occurring, gut-derived compound. It sits on the same science roadmap that connects our consumer formulations, extending our work from daily wellness into longer-horizon discovery. ACREOS™ is in active research and development, supported by issued and pending patents and collaborations with leading academic institutions. We’ll share more as the science is ready.
The evidence behind every formulation — open to read, not hidden behind a blend.
Protecting the science behind our platform.
Universities advancing the research with us.
The leaders steering Metabolica's strategy and governance.

Mr. Fields attended UCB and UCLA as an undergraduate in organic chemistry and then was in a MD/Ph.D. program at University of Southern California. He is a serial entrepreneur who successfully started and managed several companies over the past 40 years.

Dr. Auld brings 20+ years of experience in neuroscience, drug development, and research leadership. He leads operations at McGill's Victor Phillip Dahdaleh Institute of Genomic Medicine (2011–2025), co-holds two patents, and is a graduate of the adMare Executive Academy. He earned his Ph.D. from McGill and has published in leading journals including Nature, Gastroenterology, Nature Genetics and Nature Aging.

Mr. Bonnell has 30 years of leadership in capital, markets, natural resources and venture capital. He holds an LLB (Western Ontario), MSc (LSE), and MBA (McGill) and is a member of the Law Society of Upper Canada.